• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background

    Animal Vaccines Companies

    ID: MRFR/HC/5718-CR
    200 Pages
    Rahul Gotadki
    July 2025

    The animal vaccines industry had been witnessing significant growth, with several key players leading the market in the development and manufacturing of vaccines for various animals. While there might have been new developments and emerging companies in this sector since then, here are some notable companies known for their involvement in the production of animal vaccines.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Animal Vaccines Market

    Veterinary Animal Vaccines Key CompaniesLatest Veterinary/animal vaccines Companies Update



    • May 2023: The Food and Drug Administration of the United States has approved LibrelaTM (bedinvetmab injectable) for the treatment of osteoarthritis (OA)-related pain in dogs, according to a statement from Zoetis Inc. Librela is the first and only anti-NGF monoclonal antibody medication for canine OA pain that is administered once a month. It has been found to be safe and successful in giving dogs long-term relief from the symptoms of OA pain, which can enhance their mobility and general quality of life. OA discomfort can affect a dog's physical and mental well-being. The inability to climb or descend stairs easily, slow walking speed, reluctance when jumping up and down, limping after exercise, and a tendency to retreat are all indications of OA.




    • Oct 2023: Boehringer Ingelheim of Germany introduced an unbranded version of its Humira biosimilar, which has a list price of 81% less than the popular rheumatoid arthritis medication made by AbbVie. The business introduced Cyltezo in July, a branded biosimilar drug, at a price 5% less than Humira's current monthly list price of $6,922. Only the close replicas of Humira made by Boehringer can be used instead of the original without contacting a doctor after being given this interchangeability designation by the U.S. Food and Drug Administration. This year, eight Humira biosimilars from businesses, including Sandoz, a division of Novartis, and Amgen, were introduced in the United States. To compete more effectively against Humira and Cyltezo, several businesses also request interchangeability status from the FDA.List of Veterinary/animal vaccines Key companies in the market

    • Boehringer Ingelheim International GmbH (Germany)

    • Zoetis Inc. (US)

    • Ceva Santé Animale (France)

    • Merck & Co. Inc. (US)

    • Elanco Animal Health Incorporated (US)

    • Virbac (France)

    • Phibro Animal Health Corporation (US)

    • Hipra (Spain)

    • Biogénesis Bagó S.A.(Argentina)

    • Neogen Corporation (US)